{"id":"https://openalex.org/W3095539754","doi":"https://doi.org/10.1182/blood-2020-137051","title":"Targeting Pleckstrin-2 for the Treatment of Myeloproliferative Neoplasms","display_name":"Targeting Pleckstrin-2 for the Treatment of Myeloproliferative Neoplasms","publication_year":2020,"publication_date":"2020-11-05","ids":{"openalex":"https://openalex.org/W3095539754","doi":"https://doi.org/10.1182/blood-2020-137051","mag":"3095539754"},"language":"en","primary_location":{"id":"doi:10.1182/blood-2020-137051","doi":"https://doi.org/10.1182/blood-2020-137051","is_oa":false,"landing_page_url":"https://doi.org/10.1182/blood-2020-137051","pdf_url":null,"source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5082169075","display_name":"Xu Han","orcid":"https://orcid.org/0000-0001-5663-2435","observed_orcids":["https://orcid.org/0000-0001-5663-2435"]},"institutions":[{"id":"https://openalex.org/I111979921","display_name":"Northwestern University","ror":"https://ror.org/000e0be47","country_code":"US","type":"education","lineage":["https://openalex.org/I111979921"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Xu Han","raw_affiliation_strings":["Northwestern University, Chicago, IL"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Northwestern University, Chicago, IL","institution_ids":["https://openalex.org/I111979921"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5082531421","display_name":"Yang Mei","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I111979921","display_name":"Northwestern University","ror":"https://ror.org/000e0be47","country_code":"US","type":"education","lineage":["https://openalex.org/I111979921"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Yang Mei","raw_affiliation_strings":["Northwestern University, Chicago, IL"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Northwestern University, Chicago, IL","institution_ids":["https://openalex.org/I111979921"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5079762031","display_name":"Gary E. Schiltz","orcid":"https://orcid.org/0000-0003-4180-5051","observed_orcids":["https://orcid.org/0000-0003-4180-5051"]},"institutions":[{"id":"https://openalex.org/I111979921","display_name":"Northwestern University","ror":"https://ror.org/000e0be47","country_code":"US","type":"education","lineage":["https://openalex.org/I111979921"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Gary Schiltz","raw_affiliation_strings":["Northwestern University, Evanston, IL"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Northwestern University, Evanston, IL","institution_ids":["https://openalex.org/I111979921"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5059724338","display_name":"Rama K. Mishra","orcid":"https://orcid.org/0000-0003-3608-2602","observed_orcids":["https://orcid.org/0000-0003-3608-2602"]},"institutions":[{"id":"https://openalex.org/I111979921","display_name":"Northwestern University","ror":"https://ror.org/000e0be47","country_code":"US","type":"education","lineage":["https://openalex.org/I111979921"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Rama Mishra","raw_affiliation_strings":["Northwestern University, Evanston, IL"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Northwestern University, Evanston, IL","institution_ids":["https://openalex.org/I111979921"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5058648757","display_name":"Atul D. Jain","orcid":"https://orcid.org/0000-0002-3281-9729","observed_orcids":["https://orcid.org/0000-0002-3281-9729"]},"institutions":[{"id":"https://openalex.org/I111979921","display_name":"Northwestern University","ror":"https://ror.org/000e0be47","country_code":"US","type":"education","lineage":["https://openalex.org/I111979921"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Atul Jain","raw_affiliation_strings":["Northwestern University, Evanston, IL"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Northwestern University, Evanston, IL","institution_ids":["https://openalex.org/I111979921"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5042912398","display_name":"Peng Ji","orcid":"https://orcid.org/0000-0002-8849-3625","observed_orcids":["https://orcid.org/0000-0002-8849-3625"]},"institutions":[{"id":"https://openalex.org/I111979921","display_name":"Northwestern University","ror":"https://ror.org/000e0be47","country_code":"US","type":"education","lineage":["https://openalex.org/I111979921"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Peng Ji","raw_affiliation_strings":["Northwestern University, Chicago, IL"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Northwestern University, Chicago, IL","institution_ids":["https://openalex.org/I111979921"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I111979921"],"apc_list":{"value":5500,"currency":"USD","value_usd":5500},"apc_paid":null,"fwci":0.1277,"has_fulltext":false,"cited_by_count":1,"citation_normalized_percentile":{"value":0.45783053,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":93},"biblio":{"volume":"136","issue":"Supplement 1","first_page":"10","last_page":"11"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11628","display_name":"Myeloproliferative Neoplasms: Diagnosis and Treatment","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2716","display_name":"Genetics (clinical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11628","display_name":"Myeloproliferative Neoplasms: Diagnosis and Treatment","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2716","display_name":"Genetics (clinical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10746","display_name":"Platelet Disorders and Treatments","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10309","display_name":"Acute Myeloid Leukemia Research","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/myeloproliferative-neoplasms","display_name":"myeloproliferative neoplasms","score":0.9919999837875366},{"id":"https://openalex.org/keywords/jak2-stat5-signaling","display_name":"JAK2/STAT5 signaling","score":0.902999997138977},{"id":"https://openalex.org/keywords/jak2-v617f-mutation","display_name":"JAK2 V617F mutation","score":0.9430000185966492},{"id":"https://openalex.org/keywords/akt-activation","display_name":"Akt activation","score":0.6919999718666077},{"id":"https://openalex.org/keywords/dep-domain","display_name":"DEP domain","score":0.7350000143051147},{"id":"https://openalex.org/keywords/ruxolitinib","display_name":"ruxolitinib","score":0.7480000257492065},{"id":"https://openalex.org/keywords/thrombosis","display_name":"thrombosis","score":0.7400000095367432},{"id":"https://openalex.org/keywords/pten-knockout-mice","display_name":"Pten knockout mice","score":0.5759999752044678}],"concepts":[{"id":"https://openalex.org/C2776112149","wikidata":"https://www.wikidata.org/wiki/Q7383611","display_name":"Ruxolitinib","level":4,"score":0.7543021440505981},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.590740442276001},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.5197200775146484},{"id":"https://openalex.org/C2779391668","wikidata":"https://www.wikidata.org/wiki/Q4210018","display_name":"STAT5","level":3,"score":0.5070786476135254},{"id":"https://openalex.org/C109159458","wikidata":"https://www.wikidata.org/wiki/Q919283","display_name":"Haematopoiesis","level":3,"score":0.44142234325408936},{"id":"https://openalex.org/C2778729363","wikidata":"https://www.wikidata.org/wiki/Q11688946","display_name":"Myeloid leukemia","level":2,"score":0.41794922947883606},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.37485307455062866},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.3528502583503723},{"id":"https://openalex.org/C2780076729","wikidata":"https://www.wikidata.org/wiki/Q1752571","display_name":"Myelofibrosis","level":3,"score":0.3509390950202942},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.27907365560531616},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.1264851987361908},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.11802881956100464},{"id":"https://openalex.org/C28328180","wikidata":"https://www.wikidata.org/wiki/Q48196","display_name":"Stem cell","level":2,"score":0.10883674025535583},{"id":"https://openalex.org/C2780007613","wikidata":"https://www.wikidata.org/wiki/Q546523","display_name":"Bone marrow","level":2,"score":0.08768707513809204}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1182/blood-2020-137051","doi":"https://doi.org/10.1182/blood-2020-137051","is_oa":false,"landing_page_url":"https://doi.org/10.1182/blood-2020-137051","pdf_url":null,"source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.98580002784729,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2954253406","https://openalex.org/W4318671083","https://openalex.org/W2770461033","https://openalex.org/W2732799197","https://openalex.org/W2051373733","https://openalex.org/W4210352734","https://openalex.org/W2014293327","https://openalex.org/W2579225715","https://openalex.org/W3110102301","https://openalex.org/W4220869826"],"abstract_inverted_index":{"Myeloproliferative":[0],"neoplasms":[1,106],"are":[2,9,49,65],"a":[3,81,113,122,165,317,322,392,434],"group":[4],"of":[5,35,39,59,116,130,156,171,177,249,262,330,354,360,366,453],"hematopoietic":[6,265,324,348],"malignancies":[7],"that":[8,87,97,110,128,149,184,243,259,277,286],"characterized":[10],"with":[11,27,51,91,158,267,294,375,416,443],"the":[12,56,76,117,134,154,159,169,175,202,246,263,308,334,352,355,361],"activated":[13,160],"JAK2-STAT5":[14,118,161],"signaling":[15,398],"and":[16,37,137,140,163,239,296,340,358,371,385,396],"uncontrolled":[17],"myeloid":[18],"cell":[19,349],"proliferation.":[20],"Current":[21],"first":[22],"line":[23],"therapies":[24,73],"remain":[25],"suboptimal":[26],"ongoing":[28],"risks":[29],"for":[30,153,168,174,233],"thrombosis,":[31],"hemorrhage,":[32],"impaired":[33],"quality":[34],"life,":[36],"risk":[38],"transformation":[40],"to":[41,55,69,74,89,211,217,231,245,270,307,405,412,455],"acute":[42],"leukemia.":[43],"More":[44],"recent":[45],"FDA-approved":[46],"JAK":[47,218],"inhibitors":[48,173,208],"associated":[50,418],"poor":[52],"tolerance":[53],"due":[54],"key":[57],"roles":[58],"JAK2":[60],"in":[61,101,142,201,228,337,383,400,421,437,441],"normal":[62],"hematopoiesis.":[63],"There":[64],"unmet":[66],"medical":[67],"needs":[68],"develop":[70,190],"novel":[71],"targeted":[72],"treat":[75],"disease.":[77],"Pleckstrin-2":[78],"(Plek2)":[79],"is":[80,99,112,151,198,409],"widely":[82],"expressed":[83],"PH":[84],"domain-containing":[85],"protein":[86],"binds":[88],"phosphoinositide":[90],"unclear":[92],"functions.":[93],"We":[94,108],"previously":[95],"showed":[96,276],"Plek2":[98,111,131,150,172,185,207,235,287,331,356,390,408,431],"overexpressed":[100],"JAK2V617F":[102,143,372],"mutation":[103],"positive":[104],"myeloproliferative":[105,335,368,401],"(MPNs).":[107],"identified":[109,240,255],"downstream":[114],"effector":[115],"pathway.":[119,363,448],"Furthermore,":[120],"through":[121,316,351],"mouse":[123,318,327,369],"genetic":[124,319],"approach,":[125],"we":[126,225,311],"discovered":[127],"knockout":[129,186,326],"significantly":[132,332,377],"ameliorated":[133,378],"MPN":[135,379],"phenotypes":[136,380],"reverted":[138,333],"lethality":[139],"thrombosis":[141],"knock-in":[144,373],"mice.":[145],"These":[146,387],"studies":[147,254,284,388],"demonstrate":[148],"critical":[152],"pathogenesis":[155],"MPNs":[157],"pathway,":[162],"form":[164],"strong":[166],"foundation":[167],"development":[170],"treatment":[176,365],"MPNs.":[178],"Importantly,":[179],"our":[180],"published":[181],"study":[182],"shows":[183],"mice":[187,339],"do":[188],"not":[189],"anemia":[191],"or":[192,446],"cytopenia,":[193],"indicating":[194],"Plek2's":[195,314],"proto-oncogenic":[196],"function":[197,315],"mainly":[199],"manifested":[200],"disease":[203],"background,":[204],"which":[205],"makes":[206],"less":[209],"likely":[210],"cause":[212],"severe":[213],"adverse":[214],"effects":[215],"compared":[216],"inhibitor":[219],"ruxolitinib.":[220,271],"Based":[221],"on":[222],"these":[223,338],"studies,":[224],"used":[226],"an":[227,417],"silico":[229],"approach":[230,320],"screen":[232],"putative":[234],"binding":[236,290],"small":[237],"molecules":[238],"hit":[241],"compounds":[242],"bind":[244],"DEP":[247],"domain":[248],"Plek2.":[250],"Further":[251,282],"medicinal":[252],"chemistry":[253],"lead":[256],"compound":[257],"NUP-17d":[258,278,301,346,376],"inhibited":[260,279,302],"proliferation":[261,350],"hyperproliferative":[264],"cells":[266],"potency":[268],"comparable":[269],"In":[272,305,403],"addition,":[273],"biochemical":[274,309],"assays":[275],"Akt":[280,295,298],"phosphorylation.":[281],"mechanistic":[283],"revealed":[285],"promoted":[288],"Akt-PtdIns(3,4)P2":[289],"via":[291],"direct":[292],"interaction":[293],"enhanced":[297],"activation;":[299],"while":[300],"this":[303],"process.":[304],"addition":[306,404],"assays,":[310],"also":[312,410],"demonstrated":[313],"using":[321],"Pten":[323],"specific":[325],"model.":[328],"Knockout":[329],"phenotype":[336],"markedly":[341],"extended":[342],"their":[343],"survival.":[344],"Therefore,":[345,429],"blocks":[347],"disruption":[353],"complex":[357],"inhibition":[359],"PI3K-Akt":[362,397,447],"Indeed,":[364],"erythropoietin-induced":[367],"model":[370,374],"including":[381],"increase":[382],"CBC":[384],"splenomegaly.":[386],"establish":[389],"as":[391],"oncoprotein":[393],"mediating":[394],"JAK2-STAT":[395,445],"pathways":[399],"neoplasms.":[402],"hematologic":[406],"malignancies,":[407],"found":[411],"be":[413],"highly":[414],"upregulated":[415,444],"worse":[419],"prognosis":[420],"many":[422],"solid":[423],"tumors":[424],"(data":[425],"from":[426],"oncomine,":[427],"kmplot).":[428],"targeting":[430],"could":[432],"have":[433],"broad":[435],"impact":[436],"cancer":[438],"therapy,":[439],"especially":[440],"cancers":[442],"Disclosures":[449],"No":[450],"relevant":[451],"conflicts":[452],"interest":[454],"declare.":[456]},"counts_by_year":[{"year":2021,"cited_by_count":1}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2020-11-09T00:00:00"}